These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8695755

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.
    Théroux P, Pérez-Villa F, Waters D, Lespérance J, Shabani F, Bonan R.
    Circulation; 1995 Apr 15; 91(8):2132-9. PubMed ID: 7697841
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit.
    Bishop GG, McPherson JA, Sanders JM, Hesselbacher SE, Feldman MJ, McNamara CA, Gimple LW, Powers ER, Mousa SA, Sarembock IJ.
    Circulation; 2001 Apr 10; 103(14):1906-11. PubMed ID: 11294811
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Systemic thrombin inhibition by Hirulog does not alter medial smooth muscle cell proliferation and inflammatory activation after vascular injury in the rabbit.
    Kranzhöfer R, Maraganore JM, Baciu R, Libby P.
    Cardiovasc Drugs Ther; 1999 Sep 10; 13(5):429-34. PubMed ID: 10547223
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparative safety profiles of hirulog and heparin in patients undergoing coronary angioplasty. The Hirulog Angioplasty Study Investigators.
    Bittl JA.
    Am Heart J; 1995 Sep 10; 130(3 Pt 2):658-65. PubMed ID: 7668214
    [Abstract] [Full Text] [Related]

  • 35. Vascular reactivity after balloon angioplasty in an atherosclerotic rabbit.
    La Veau PJ, Sarembock IJ, Sigal SL, Yang TL, Ezekowitz MD.
    Circulation; 1990 Nov 10; 82(5):1790-801. PubMed ID: 2146042
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Atherosclerotic rabbit iliac arteries: comparison of balloon angioplasty and laser-assisted balloon angioplasty.
    Consigny PM, Gardiner GA.
    J Vasc Interv Radiol; 1991 May 10; 2(2):253-60. PubMed ID: 1839236
    [Abstract] [Full Text] [Related]

  • 38. Effective use of BCH-2763, a new potent injectable direct thrombin inhibitor, in combination with tissue plasminogen activator (tPA) in a rat arterial thrombolysis model.
    Deschênes I, Finkle CD, Winocour PD.
    Thromb Haemost; 1998 Jul 10; 80(1):186-91. PubMed ID: 9684808
    [Abstract] [Full Text] [Related]

  • 39. Clinical trials of Hirulog in patients undergoing high-risk percutaneous transluminal coronary angioplasty.
    Bittl JA.
    Coron Artery Dis; 1996 Jun 10; 7(6):449-54. PubMed ID: 8889360
    [No Abstract] [Full Text] [Related]

  • 40. A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction.
    Lidón RM, Théroux P, Lespérance J, Adelman B, Bonan R, Duval D, Lévesque J.
    Circulation; 1994 Apr 10; 89(4):1567-72. PubMed ID: 8149522
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.